Objective: To characterize the pharmacokinetic-pharmacodynamic correlation of intranasal and intravenous fentanyl in opioid-naïve patients undergoing third molar extraction. Methods: A double ...

The ALS Association has awarded a “groundbreaking” grant to Tiziana Life Sciences to support a small, early-stage clinical trial testing foralumab nasal spray for amyotrophic lateral sclerosis (ALS).

Medications delivered by such a means include fentanyl transmucosal lozenges, sublingual nitroglycerin, and intranasal DDAVP, and have existed with great clinical success for many years.